Head-to-head
Oak Longevity vs Ivim Health
Compared on semaglutide across the eight dimensions this database records. They differ on 5 of those eight. Oak Longevity is cheaper on all-in semaglutide at 2.4 mg/week, though on a flat-versus-tiered matchup the cheaper program can change further up the dose ladder.
The short answer
Oak Longevity is $133 a month all-in for semaglutide; Ivim Health is $224. Over twelve months that is $1,596 against $2,688. Value Scores are 95.6 and 53.1 out of 100.
Semaglutide
Plan pages: Oak Longevity plans · Ivim Health plans
At 2.4 mg/week, Oak Longevity is $133 a month all-in and Ivim Health is $224 — $91 apart, or $1,092 across a year. Over twelve months the totals are $1,596 (billed monthly) and $2,688 (billed monthly).
Oak Longevity charges a flat $133 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay.
Ivim Health charges a flat $149 per month for semaglutide at every dose from 0.25 to 2.4 mg per week, so titrating upward does not change what you pay. The company publishes no price at 0.5, 1, 1.7 mg, so those doses are left blank rather than estimated.
| Dose | Oak Longevity | Rank | Ivim Health | Rank | Cheaper |
|---|---|---|---|---|---|
| 0.25 mg | $133 | 4/32 | $149 | 7/32 | Oak Longevity by $16 |
| 0.5 mg | $133 | 3/21 | — | — | only Oak Longevity publishes |
| 1 mg | $133 | 3/21 | — | — | only Oak Longevity publishes |
| 1.7 mg | $133 | 3/21 | — | — | only Oak Longevity publishes |
| 2.4 mg | $133 | 3/29 | $149 | 6/29 | Oak Longevity by $16 |
Oak Longevity is cheaper at every dose where both publish a price, so the lead does not change as you titrate.
Across the 29 programs this database can rank on semaglutide, Oak Longevity sits 2 of 29 on all-in monthly cost and Ivim Health sits 14. There are 11 other programs priced between them. The field median is $249 and the floor is $129, so both sit below the median. Oak Longevity is $4 above the cheapest semaglutide program on record. Ivim Health is $95 above the cheapest semaglutide program on record.
NovoCare Pharmacy (Wegovy), the lowest FDA-approved semaglutide channel here, is $349 a month — Oak Longevity undercuts it by $216, Ivim Health by $125. Compounded products are not FDA approved; insurance can reverse that comparison.
| Plan term | Oak Longevity | Ivim Health | Cheaper |
|---|---|---|---|
| Month to month | $133 | $149 | Oak Longevity by $16 |
| Settled dose | Oak Longevity | Ivim Health | Difference |
|---|---|---|---|
| 0.25 mg | $1,596 | $2,688 | $1,092 apart |
| 0.5 mg | $1,596 | — | one side unpriced |
| 1 mg | $1,596 | — | one side unpriced |
| 1.7 mg | $1,596 | — | one side unpriced |
| 2.4 mg | $1,596 | $2,688 | $1,092 apart |
Oak Longevity publishes no rate for 3-month term, 6-month term, 12-month term; Ivim Health publishes none for 3-month term, 6-month term, 12-month term. An unpublished term is not necessarily unavailable — it is unpriced in public, which you can only resolve by asking.
A titration year is not twelve months at the maintenance price. Stepping up roughly four weeks per dose before settling at 2.4 mg/week, the first twelve months work out to $1,596 on Oak Longevity and $2,688 on Ivim Health. The ramp is cheaper than the settled rate on whichever program prices by dose, which is why a first-year quote and a steady-state quote are not the same number.
That calculation is partial: Ivim Health publishes no price at 3 of them, so the maintenance rate stands in for the missing steps rather than a number the company has stated.
Value Scores are 95.6 for Oak Longevity and 53.1 for Ivim Health, against a semaglutide category floor of $129. Oak Longevity leads by 42.5 points, driven mostly by price.
| Program | Price /70 | Evidence /15 | Dose /10 | Membership /5 | Total /100 |
|---|---|---|---|---|---|
| Oak Longevity | 67.9 | 12.8 | 10 | 5 | 95.6 |
| Ivim Health | 40.3 | 12.8 | 0 | 0 | 53.1 |
Where the two programs differ
All-in monthly
Oak Longevity is cheaper month to month — $133 against $224, a gap of $91 every month, or $1,092 across a year if both rates hold.
Cancellation terms
Cancellation differs: Oak Longevity states Cancel before renewal, while Ivim Health states Cancel anytime. Read this next to the twelve-month figures — a prepaid discount and a restrictive refund policy are the same decision.
Dose policy
Oak Longevity charges one price at every dose; Ivim Health prices by dose. That difference usually matters more than the headline gap, because the tiered program's advertised figure describes the dose you start on, not the dose you settle at.
Membership fee
Ivim Health charges a membership of $75 a month on top of the medication. That is already folded into the all-in figures above — it is broken out here because a membership is a recurring charge that continues even in a month you skip a shipment.
Twelve-month cost
Over twelve months the totals are $1,596 for Oak Longevity and $2,688 for Ivim Health. Oak Longevity is lower by $1,092 — a figure worth checking against the cancellation terms below, because a prepaid year is only cheaper if you stay on it.
Commitment
Commitment terms read the same on both: Month-to-month.
Evidence status
Both figures carry the same evidence status, provider-stated: taken from the provider's own published pages; checkout capture pending. Neither is stronger than the other on provenance.
Shipping
Shipping is handled the same way by both — included in the quoted price.
What each record says
Oak Longevity Official site
A small cash-pay telehealth program whose $133/month flat semaglutide price is currently the lowest month-to-month figure in our semaglutide index.
It does not publicly name its compounding pharmacy; the record shows Partner 503A pharmacy (not publicly itemized), so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel before renewal; availability is stated as Availability confirmed at intake.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — First-party pricing page capture 2026-08-08
Watch: Small operator; pharmacy partner not publicly itemized. Price captured from the provider's published pages; checkout capture pending.
Ivim Health Official site
Ivim combines a $75/month membership with tiered medication pricing; its all-in semaglutide figure ($149) is competitive, while tirzepatide lands mid-pack at $278 all-in at the 10 mg basis.
It does not publicly name its compounding pharmacy; the record shows Partner pharmacies, so who actually makes the medication cannot be independently verified; commitment terms are Month-to-month; cancellation is Cancel anytime; availability is stated as ~50 states.
Evidence: provider-stated — taken from the provider's own published pages; checkout capture pending, captured . Source — ivimhealth.com pricing captures 2026-08-05
Watch: Dose-tiered tirzepatide means the advertised start price understates maintenance cost; compare on the maintenance column.
Which molecules each one carries
Oak Longevity carries semaglutide at $133 a month; does not offer tirzepatide.
Ivim Health carries tirzepatide at $353 a month and semaglutide at $224 a month.
Comparable only on semaglutide: they do not both publish a rankable tirzepatide price. Switching molecule mid-treatment would mean changing provider.
What neither record tells you
Oak Longevity does not publish
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says Availability confirmed at intake
Ivim Health does not publish
- no semaglutide price at 0.5, 1, 1.7 mg per week
- no published twelve-month semaglutide rate
- no named compounding pharmacy
- no state-by-state availability list — it says ~50 states
Ask Oak Longevity and Ivim Health for each of those in writing before enrolling. A gap is not evidence of a problem; it does mean nothing can be checked against it.
What would change this answer
Neither program publishes a promotional rate with an end date, a prepaid term, or a price we have flagged for re-verification, so the comparison above is as stable as this dataset gets.
Which one suits which reader
On the lowest standing monthly rate for semaglutide, Oak Longevity Official site wins this matchup. If you expect to titrate to the top of the ladder, oak longevity's flat pricing is worth more than the headline gap suggests; if you want to be able to pause without still paying, oak longevity carries no membership.
Both figures should be checked at the provider's own checkout before you pay. Oak Longevity's semaglutide price is provider-stated as of 2026-08-08; Ivim Health's is provider-stated as of 2026-08-05.
Questions
Is Oak Longevity or Ivim Health cheaper for semaglutide?
Oak Longevity is cheaper on all-in monthly cost at 2.4 mg/week: $133 against $224, a difference of $91 a month. All-in means the medication plus every mandatory recurring fee.
What is the twelve-month cost of Oak Longevity versus Ivim Health?
Oak Longevity works out to $1,596 across twelve months and Ivim Health to $2,688, on the plan terms each publishes.
Does Oak Longevity or Ivim Health raise the price as the dose goes up?
Oak Longevity: no, it charges one flat rate at every dose. Ivim Health: yes, it prices by dose. Where one program is flat and the other is tiered, the cheaper of the two can change as you titrate upward.
How many ways do Oak Longevity and Ivim Health differ?
5 of the eight dimensions this site records: all-in monthly, twelve-month cost, dose policy, membership, shipping, commitment, cancellation terms and evidence status.
Which of Oak Longevity and Ivim Health names its pharmacy?
Neither. Oak Longevity records Partner 503A pharmacy (not publicly itemized) and Ivim Health records Partner pharmacies. Without a named pharmacy, neither program's licensing or inspection history can be checked before you order.
How well evidenced are the Oak Longevity and Ivim Health prices?
Oak Longevity's semaglutide figure is provider-stated — taken from the provider's own published pages; checkout capture pending — captured 2026-08-08. Ivim Health's is provider-stated, captured 2026-08-05. Evidence status is worth fifteen points in the Value Score, so it is priced in rather than mentioned as an aside.
Official sources: Oak Longevity official site · Ivim Health official site. Compounded tirzepatide and semaglutide are not FDA-approved products.